Target intelligence / Profile preview

Barttin CLCNK-type chloride channel accessory beta subunit pseudogene 4 (BSNDP4)

Target
BSNDP4
Molecular classification
Other (Pseudogene)
01

Overview

BSND pseudogene 4 (BSNDP4) is classified as a pseudogene, which means it is a DNA sequence similar to a functional gene (in this case, the BSND gene encoding barttin) but is generally considered non-functional and does not produce a protein product[8][6]. There are no known biological functions, disease associations, or drug interactions attributed to BSNDP4. The primary relevance of this sequence is its similarity to the functional BSND gene involved in chloride channel activity and associated disease (Bartter syndrome); however, BSNDP4 itself does not encode any known protein or serve as a therapeutic target[8][6]. Additional details: - This pseudogene is cataloged with gene identifiers such as HGNC:51539, NCBI Gene:106481726, and Ensembl:ENSG00000229627[8][6]. - No evidence exists in current sources that BSNDP4 is functional, is associated with disease, or interacts with drugs[8][6]. - By convention and based on database records, "BSND pseudogene 4" refers specifically to the pseudogene, not the functional BSND gene/protein. Note: This entry should not be confused with the functional BSND (“Barttin CLCNK-type accessory subunit beta”) gene, which is critical for chloride channel regulation and associated with Bartter syndrome and sensorineural deafness[1][7][3][5]. BSNDP4 is a non-functional genomic segment with no direct role as a therapeutic or diagnostic target.

Other names
barttin CLCNK-type chloride channel accessory beta subunit pseudogene 4barttin CLCNK type accessory beta subunit pseudogene 4BSNDP4

Beyond the preview

Go deeper on Barttin CLCNK-type chloride channel accessory beta subunit pseudogene 4 (BSNDP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barttin CLCNK-type chloride channel accessory beta subunit pseudogene 4 (BSNDP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call